Isoniazid resistant tuberculosis(Hr-TB): a problem well stated is a problem half solved! - Milan 2023

What is new in treatment of drug-susceptible tuberculosis, drug-resistant tuberculosis and tuberculosis infection?

Chair(s): Liga Kuksa, Jan Heyckendorf

Session type: Poster session

Isoniazid resistant tuberculosis(Hr-TB): a problem well stated is a problem half solved!

KETAN MALU

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

The use of weekly rifapentine and isoniazid (3HP) for latent TB infection in Australia.

Vicky Chang

Poster

Abstract

TREATMENT OUTCOMES OF EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS (XDR-TB) IN MONGOLIA: RETROSPECTIVE STUDY

Bolyskhan Baigabyl

Poster

Abstract

Side effects of 2nd line anti-tuberculous drugs: impact on compliance and therapeutic efficacy

Soumaya Ben Saad

Poster

Abstract

Isoniazid resistant tuberculosis(Hr-TB): a problem well stated is a problem half solved!

Ketan Malu

Poster

Abstract

Study of Moxifloxacin and Silver Nanoparticle Composite Efficacy on pre-XDR Mycobacterium Tuberculosis Strains

Teona Avaliani

Abstract

Dexamethasone Reduces Metabolic Function and Subsequent Activation of Human Macrophages to Mycobacterium Tuberculosis.

Lorraine Thong

Poster

Abstract

Outcome of Multi drug resistant(MDR)TB patients on Shorter MDR TB Regimen

Jyoti Bajpai

Abstract

Features of the treatment outcome of patients with multidrug-resistant tuberculosis and Beijing lineage 2 of Mycobacterium tuberculosis in Kharkiv region, Ukraine

Dmytro Butov

Poster

Abstract

Relationship between PTLD and multidrug resistance to Tuberculosis

Angela Maria Giraldo Montoya

Poster

Abstract

Seventeen drugs, one sample: analyzing multiple anti-TB drugs simultaneously using one method

Mathieu S. Bolhuis

Poster

Abstract

A 15 year Retrospective Analysis of the Impact of Hearing Loss following IV Aminoglycoside use for Multi-Drug Resistant Tuberculosis

Ciara Ottewill

Poster

Abstract

Adjunctive Corticosteroid Therapy for severe tuberculosis: Risk factors for poor outcomes?

Amani Ben Mansour

Poster

Abstract

Linezolid-induced peripheral neuropathy in patients receiving MDR-TB treatment

Erik Skyllberg

Poster

Abstract

Carbapenems and amoxicillin together with B-lactamase inhibitors for the treatment of Tuberculosis, a systematic review.

Carlijn Veldman

Poster

Abstract

Release of potassium ions from leukocytes in patients with tuberculosis with toxic-allergic reactions to medicines

Galyna Gumeniuk

Poster

Abstract

Effect of tuberculosis preventive treatment on household contacts of rifampin-resistant tuberculosis patients: A nationwide investigation

Kang-mo Gu

Poster

Abstract

Efficacy and safety of 6-month and 4-month anti-tuberculosis regimens: A review of literature and meta-analysis

Stephanie Palacios

Poster

Abstract

Molecular Characterization of Drug Resistant pattern of Mycobacterium tuberculosis

Sushma Yadav

Poster

Abstract

Characterization of tuberculosis drug resistance patterns in the early days of XDR-TB

Andre Filipe Santos Nunes

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}